Fumio Nakagawa

1.5k total citations
61 papers, 1.2k citations indexed

About

Fumio Nakagawa is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fumio Nakagawa has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 20 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fumio Nakagawa's work include Colorectal Cancer Treatments and Studies (22 papers), Gastric Cancer Management and Outcomes (10 papers) and Biochemical and Molecular Research (6 papers). Fumio Nakagawa is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Gastric Cancer Management and Outcomes (10 papers) and Biochemical and Molecular Research (6 papers). Fumio Nakagawa collaborates with scholars based in Japan, United States and Germany. Fumio Nakagawa's co-authors include Teiji Takechi, Masakazu Fukushima, Junji Uchida, Kenji Kitazato, Hiroyuki Okabe, Mamoru Nukatsuka, Tomohiro Emura, Akio Fujioka, Kenichi Matsuo and Yuko Murakami and has published in prestigious journals such as Cancer Research, FEBS Letters and International Journal of Molecular Sciences.

In The Last Decade

Fumio Nakagawa

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumio Nakagawa Japan 20 682 381 299 151 150 61 1.2k
B. F. El-Rayes United States 19 615 0.9× 348 0.9× 385 1.3× 98 0.6× 166 1.1× 38 1.2k
C.J.A. van Moorsel Netherlands 14 644 0.9× 445 1.2× 333 1.1× 116 0.8× 157 1.0× 16 1.1k
M. Lehnert Switzerland 19 702 1.0× 361 0.9× 154 0.5× 176 1.2× 87 0.6× 40 1.1k
Derk Jan A. de Groot Netherlands 17 865 1.3× 336 0.9× 186 0.6× 121 0.8× 246 1.6× 35 1.4k
Chung-Tsen Hsueh United States 19 556 0.8× 416 1.1× 305 1.0× 93 0.6× 112 0.7× 55 1.2k
Isabelle Hennebelle France 19 726 1.1× 506 1.3× 188 0.6× 97 0.6× 91 0.6× 25 1.1k
R F Ozols United States 17 723 1.1× 606 1.6× 250 0.8× 207 1.4× 149 1.0× 29 1.4k
Daphne Voorn Netherlands 16 539 0.8× 389 1.0× 213 0.7× 90 0.6× 108 0.7× 21 911
Satoru Iida Japan 24 586 0.9× 791 2.1× 280 0.9× 290 1.9× 228 1.5× 58 1.5k
V. Damiano Italy 15 796 1.2× 502 1.3× 568 1.9× 78 0.5× 105 0.7× 34 1.3k

Countries citing papers authored by Fumio Nakagawa

Since Specialization
Citations

This map shows the geographic impact of Fumio Nakagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Nakagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Nakagawa more than expected).

Fields of papers citing papers by Fumio Nakagawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Nakagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Nakagawa. The network helps show where Fumio Nakagawa may publish in the future.

Co-authorship network of co-authors of Fumio Nakagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Nakagawa. A scholar is included among the top collaborators of Fumio Nakagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Nakagawa. Fumio Nakagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujiwara, Yuta, Kentarō Hayashi, Yohei Shibata, et al.. (2023). Cerebral tumor embolism from thyroid cancer treated by mechanical thrombectomy: illustrative case. Journal of Neurosurgery Case Lessons. 5(5). 2 indexed citations
2.
Irie, Hiroki, Fumio Nakagawa, Hiraku Itadani, et al.. (2020). Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728. Cancer Science. 111(6). 2123–2131. 26 indexed citations
3.
Miyazaki, Takeshi, Shinichi Yasuda, Yuta Fujiwara, et al.. (2020). Aggressive Intraoperative Cisternal Clot Removal After Clipping Aneurismal Subarachnoid Hemorrhage in Elderly Patients. World Neurosurgery. 147. e482–e490. 8 indexed citations
4.
Muraoka, Hiromi, Shingo Tsuji, Akihiro Hashimoto, et al.. (2019). TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models. Molecular Cancer Therapeutics. 18(7). 1205–1216. 51 indexed citations
5.
Matsuoka, Kazuaki, Fumio Nakagawa, Junji Uchida, & Teiji Takechi. (2018). Abstract 1867: Combined and sequential chemotherapy efficacy of trifluridine/tipiracil and regorafenib in colorectal cancer cell lines. Cancer Research. 78(13_Supplement). 1867–1867.
6.
Suzuki, Norihiko, Fumio Nakagawa, Kazuaki Matsuoka, & Teiji Takechi. (2016). Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts. Oncology Reports. 36(6). 3123–3130. 11 indexed citations
7.
Tanaka, Nozomu, Kazuki Sakamoto, Hiroyuki Okabe, et al.. (2014). Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models. Oncology Reports. 32(6). 2319–2326. 105 indexed citations
8.
Sakamoto, Katsumi, Nozomu Tanaka, Akira Fujioka, et al.. (2014). 22 Novel combination therapy, TAS-102 combined with the anti-EGFR antibody or the anti-VEGF antibody showed therapeutic benefit toward colorectal cancer xenografts. European Journal of Cancer. 50. 13–13. 2 indexed citations
9.
Tsujimoto, Hiroaki, Sayaka Tsukioka, Satoru Ono, et al.. (2010). Effect of leucovorin on the antitumor efficacy of the 5-FU prodrug, tegafur-uracil, in human colorectal cancer xenografts with various expression levels of thymidylate synthase. Oncology Letters. 1(6). 973–980. 12 indexed citations
10.
Nukatsuka, Mamoru, Hitoshi Saitô, Fumio Nakagawa, et al.. (2010). Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts. Breast Cancer Research and Treatment. 128(2). 381–390. 11 indexed citations
11.
Tsujimoto, Hiroaki, Sayaka Tsukioka, Fumio Nakagawa, et al.. (2007). [Benefits of TS-1 plus leucovorin combination therapy for colorectal cancer: evaluation of therapeutic effect of TS-1 and leucovorin combination therapy using rodent model fed a low folate diet].. PubMed. 34(3). 413–8. 2 indexed citations
12.
Nakagawa, Fumio, et al.. (2004). Double Anterior (Anterolateral and Anteromedial) Thigh Flaps for Reconstruction of Head and Neck Defects. Nippon Jibiinkoka Gakkai Kaiho. 107(6). 645–652. 3 indexed citations
13.
Suga, Junko, et al.. (2003). Studies on the Stability of Polaprezinc Suspension Dispersed in Sodium Alginate Solution.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29(1). 56–61. 1 indexed citations
14.
Saito, Ryusuke, et al.. (2003). Surgical intervention in middle-ear cholesterol granuloma. The Journal of Laryngology & Otology. 117(5). 344–348. 8 indexed citations
15.
Shimamoto, Yuji, Hiroyuki Okabe, Hiromi Kazuno, et al.. (2002). Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2. Japanese Journal of Cancer Research. 93(7). 825–833. 48 indexed citations
16.
17.
Ogawa, Teruhiro, et al.. (1993). A Case of Carcinoid Tumor in the Sphenoid Sinus. Practica oto-rhino-laryngologica Suppl. 1993(Supplement64). 106–112. 2 indexed citations
18.
Nakagawa, Fumio, et al.. (1984). Terferol, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I Isolation and characterization.. The Journal of Antibiotics. 37(1). 6–9. 18 indexed citations
19.
Nakagawa, Fumio, Kentaro Kodama, Kouhei Furuya, & Atsushi Naito. (1979). New Strains of Botryodiplodin-producing Fungi. Agricultural and Biological Chemistry. 43(7). 1597–1598. 5 indexed citations
20.
Nakagawa, Fumio, Kentaro Kodama, Kouhei Furuya, & Atsushi Naito. (1979). New strains of botryodiplodinproducing fungi.. Agricultural and Biological Chemistry. 43(7). 1597–1598. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. F. El-Rayes Breakdown of academic impact, for papers by C.J.A. van Moorsel Breakdown of academic impact, for papers by M. Lehnert Breakdown of academic impact, for papers by Derk Jan A. de Groot Breakdown of academic impact, for papers by Chung-Tsen Hsueh Breakdown of academic impact, for papers by Isabelle Hennebelle Breakdown of academic impact, for papers by R F Ozols Breakdown of academic impact, for papers by Daphne Voorn Breakdown of academic impact, for papers by Satoru Iida Breakdown of academic impact, for papers by V. Damiano
Rankless by CCL
2026